119 related articles for article (PubMed ID: 3417288)
1. Observer variation in histologic classification of malignant and borderline ovarian tumors.
Stalsberg H; Abeler V; Blom GP; Bostad L; Skarland E; Westgaard G
Hum Pathol; 1988 Sep; 19(9):1030-5. PubMed ID: 3417288
[TBL] [Abstract][Full Text] [Related]
2. Interobserver variability in the interpretation of epithelial ovarian cancer.
Hernandez E; Bhagavan BS; Parmley TH; Rosenshein NB
Gynecol Oncol; 1984 Jan; 17(1):117-23. PubMed ID: 6693048
[TBL] [Abstract][Full Text] [Related]
3. Observer disagreement in histological classification of ovarian tumors in Japan.
Sakamoto A; Sasaki H; Furusato M; Suzuki M; Hirai Y; Tsugane S; Fukushima M; Terashima Y
Gynecol Oncol; 1994 Jul; 54(1):54-8. PubMed ID: 8020839
[TBL] [Abstract][Full Text] [Related]
4. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
[TBL] [Abstract][Full Text] [Related]
5. Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing.
Baak JP; Langley FA; Talerman A; Delemarre JF
Anal Quant Cytol Histol; 1986 Dec; 8(4):354-7. PubMed ID: 3814303
[TBL] [Abstract][Full Text] [Related]
6. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Hauptmann S; Friedrich K; Redline R; Avril S
Virchows Arch; 2017 Feb; 470(2):125-142. PubMed ID: 28025670
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implications.
Lund B; Thomsen HK; Olsen J
APMIS; 1991 Apr; 99(4):353-8. PubMed ID: 2036219
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian epithelial tumors of borderline malignancy].
Katoh K; Izumi R
Rinsho Byori; 1992 Feb; 40(2):119-31. PubMed ID: 1583784
[TBL] [Abstract][Full Text] [Related]
9. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
[TBL] [Abstract][Full Text] [Related]
11. Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies.
Barnard ME; Pyden A; Rice MS; Linares M; Tworoger SS; Howitt BE; Meserve EE; Hecht JL
Gynecol Oncol; 2018 Sep; 150(3):521-526. PubMed ID: 30001835
[TBL] [Abstract][Full Text] [Related]
12. Pathology of borderline and invasive cancers.
Prat J
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():15-30. PubMed ID: 28277307
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers. With emphasis on methodology.
Cramer SF; Roth LM; Ulbright TM; Mazur MT; Nunez CA; Gersell DJ; Mills SE; Kraus FT
Arch Pathol Lab Med; 1987 Sep; 111(9):819-29. PubMed ID: 3632299
[TBL] [Abstract][Full Text] [Related]
14. Use of ultrasound pattern recognition by expert operators to identify borderline ovarian tumors: a study of diagnostic performance and interobserver agreement.
Yazbek J; Ameye L; Timmerman D; Testa AC; Valentin L; Holland TK; Van Holsbeke C; Jurkovic D
Ultrasound Obstet Gynecol; 2010 Jan; 35(1):84-8. PubMed ID: 19746450
[TBL] [Abstract][Full Text] [Related]
15. [Histological classification in 10 288 cases of ovarian malignant tumors in China].
Shi Y; Ye D; Lu W; Zhao C; Xu J; Chen L
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):97-100. PubMed ID: 11953074
[TBL] [Abstract][Full Text] [Related]
16. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
Malpica A; Deavers MT; Tornos C; Kurman RJ; Soslow R; Seidman JD; Munsell MF; Gaertner E; Frishberg D; Silva EG
Am J Surg Pathol; 2007 Aug; 31(8):1168-74. PubMed ID: 17667538
[TBL] [Abstract][Full Text] [Related]
17. Grading ovarian tumors. Evaluation of decision making by different pathologists.
Baak JP; Delemarre JF; Langley FA; Talerman A
Anal Quant Cytol Histol; 1986 Dec; 8(4):349-53. PubMed ID: 3814302
[TBL] [Abstract][Full Text] [Related]
18. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M
J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911
[TBL] [Abstract][Full Text] [Related]
20. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
Seidman JD; Kurman RJ
Hum Pathol; 2000 May; 31(5):539-57. PubMed ID: 10836293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
